Home

VICENTE ANIDO JR

CIK 1207633 · Chief Executive Officer · last filed 2021-02-25

VICENTE ANIDO JR is a Chief Executive Officer who has filed 56 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing shows the insider had shares withheld for taxes covering $26.6K of AERI on Feb 25, 2021. Across all open-market trades the lifetime net is −$11.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.0K across reported positions. 3 SEC filings were submitted jointly with QLT INC/BC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$4.0K

Companies

5

Total Filings

56

Lifetime Open-Market Net

-$11.35M

Filer Profile

Reported Address
1621 BAYSIDE DR
CORONA DEL MAR, CA 92625
Related Filers
QLT INC/BC — 3 joint filings, latest 2013-07-17
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AERIE PHARMACEUTICALS INC (AERI) Delisted Chief Executive Officer 243,896 $15.25 $3.72M -$11.66M 22 2021-02-25
Assertio Therapeutics, Inc (DEPO) Delisted Director 4,403 — — $0 6 2016-05-13
QLTI Director — $26.49 — $0 2 2013-07-17
ISTA PHARMACEUTICALS INC (ISTA) Delisted President & CEO 500,659 — — $315.1K 23 2012-05-10
AHG Director 5,333 $0.75 $4.0K $0 1 2007-05-07

Recent Filings

56 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-02-25 AERIE PHARMACEUTICALS INC (AERI) Delisted Tax (F) −1,700 -$26.6K EDGAR
2021-02-09 AERIE PHARMACEUTICALS INC (AERI) Delisted Tax (F) −7,954 -$140.7K EDGAR
2021-02-08 AERIE PHARMACEUTICALS INC (AERI) Delisted Grant (A) +28,000 $0 EDGAR
2020-05-18 AERIE PHARMACEUTICALS INC (AERI) Delisted Tax (F) −4,746 -$70.5K EDGAR
2020-02-25 AERIE PHARMACEUTICALS INC (AERI) Delisted Tax (F) −2,579 -$53.7K EDGAR
2020-02-11 AERIE PHARMACEUTICALS INC (AERI) Delisted Tax (F) −3,256 -$66.7K EDGAR
2020-02-10 AERIE PHARMACEUTICALS INC (AERI) Delisted Mixed +30,250 $0 EDGAR
2019-09-09 AERIE PHARMACEUTICALS INC (AERI) Delisted Buy (P) +26,250 $499.0K EDGAR
2019-05-17 AERIE PHARMACEUTICALS INC (AERI) Delisted Mixed +28,026 -$168.0K EDGAR
2019-04-15 AERIE PHARMACEUTICALS INC (AERI) Delisted Tax (F) −2,612 -$109.4K EDGAR
Showing 1–10 of 56
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.